DRAK2, a lymphoid-enriched DAP kinase, regulates the TCR activation threshold during thymocyte selection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

DRAK2, a lymphoid-enriched DAP kinase, regulates the TCR activation threshold during thymocyte selection

Published:2005-09-19 Issue:11 Volume:17 Page:1379-1390
ISSN:1460-2377
Container-title:International Immunology
language:en
Short-container-title:

Author:

Friedrich Monica L.,Wen Ben G.,Bain Gretchen,Kee Barbara L.,Katayama Carol,Murre Cornelis,Hedrick Stephen M.,Walsh Craig M.

Publisher

Oxford University Press (OUP)

Subject

Immunology,General Medicine,Immunology and Allergy

Link

http://academic.oup.com/intimm/article-pdf/17/11/1379/2432459/dxh315.pdf

Reference39 articles.

1. McGargill, M. A., Wen, B. G., Walsh, C. M. and Hedrick, S. M. 2004. A deficiency in Drak2 results in a T cell hypersensitivity and an unexpected resistance to autoimmunity. Immunity21:781.

2. Kogel, D., Prehn, J. H. and Scheidtmann, K. H. 2001. The DAP kinase family of pro-apoptotic proteins: novel players in the apoptotic game. Bioessays23:352.

3. Cohen, O., Feinstein, E. and Kimchi, A. 1997. DAP-kinase is a Ca2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J.16:998.

4. Cohen, O. and Kimchi, A. 2001. DAP-kinase: from functional gene cloning to establishment of its role in apoptosis and cancer. Cell Death Differ.8:6.

5. Raveh, T., Berissi, H., Eisenstein, M., Spivak, T. and Kimchi, A. 2000. A functional genetic screen identifies regions at the C-terminal tail and death-domain of death-associated protein kinase that are critical for its proapoptotic activity. Proc. Natl Acad. Sci. USA97:1572.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T cell development;Cell Reports;2023-02

2. New insights into the characteristics of DRAK2 and its role in apoptosis: From molecular mechanisms to clinically applied potential;Frontiers in Pharmacology;2022-10-28

3. Total Synthesis of (+)‐Alstonlarsine A;Angewandte Chemie International Edition;2022-08-23

4. Total Synthesis of (+)‐Alstonlarsine A;Angewandte Chemie;2022-08-23

5. The Emerging Key Role of the mGluR1-PKCγ Signaling Pathway in the Pathogenesis of Spinocerebellar Ataxias: A Neurodevelopmental Viewpoint;International Journal of Molecular Sciences;2022-08-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3